sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Tue Mar 31
Galaxy Digital Leads Investment In Blockchain Startup Fence
2d
Y
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
2d
Y
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
2d
Y
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
2d
Y
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
2d
Y
Opes Wealth Sells Its Entire FIXD Stake -- Is This $9.3 Million Bond ETF Exit A Signal?
2d
Y
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
2d
Y
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
2d
Y
Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at
2d
Y
Fed Decision Looms, Tech Earnings Could Drive Volatile Session: Dow Jones, S&P, Nasdaq, Wall Street Futures
2d
Y
They Built A Career In Mechanical Engineering. Now They're Stuck In The 'Overqualified Trap' And Can't Even Get Hired At A Grocery Store
2d
Y
GE Vernova: This Brand New Energy Player Could Be the 1 Stock You'll Wish You'd Bought in 2026
2d
Y
As Marvell Acquires Polariton, Should You Buy, Sell, or Hold MRVL Stock?
2d
Y
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?
2d
Y
In A Victory, Gemini Put In Four Million GM Cars
2d
Y
AbbVie beats Q1 2026 earnings, raises full-year forecast
2d
Y
Ex-Mars CEO named Lipton chair
2d
Y
Robinhood's crypto revenue tanks 47%, gap filled by prediction markets
2d
Y
Regeneron Slumps On An Unexpected Setback For Its Bread-And-Butter Drug
2d
Y
BMW i Ventures has a new $300M fund and AI is riding shotgun
2d
Y
Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results
2d
Y
Seagate Stock Soars After AI Demand Powers Big Earnings Beat
2d
Y
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?
2d
Y
Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight
2d
Y
Treasury Yields Rise as Powell Confirms He Is Staying on Fed Board
2d
Y
Should You Be Bullish on Natera (NTRA)?
2d
Y
Startup Blockworks wants to become the crypto equivalent of Morningstar. How it plans to do it
2d
F
Why data storage stocks are a key AI play
2d
Y
GM Q1 Earnings Blowout: Top Auto Stock EPS Growth Hits 33%
2d
S
Federal Reserve holds interest rates steady as divisions emerge, Powell announces he'll stay on as governor
2d
Y
Fed meeting today: Central bank 'firmly parked' on interest rate pause
2d
Y
Teva Surges 12% — And It's Not Completely Tied To Earnings
2d
Y
'Did I save too much?': Your 401(k) may be at all-time highs, but big balances carry hidden retirement risks
2d
Y
Meta Stock Edges Lower With Q1 Results Due. Here Are 2 Earnings Numbers To Watch.
2d
Y
Prepare For A Pullback Because Q2 Is Going To Be Ugly
2d
S
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
2d
Y
Daily – Vickers Top Insider Picks for 04/29/2026
2d
Y
Daily – Vickers Top Buyers & Sellers for 04/29/2026
2d
Y
German, Spanish Inflation Reach Multiyear Highs
2d
Y
What Makes Rollins (ROL) an Attractive Investment?
2d
Y
Polen Focus Growth Bets on Lam Research (LRCX), a Critical Supplier of Etch and Deposition Equipment
2d
Y
AbbVie Shakes Off The 'Negative Sentiment' That Clouded Its Big Beat
2d
Y
Here’s What Pressured CoStar Group (CSGP) in Q1
2d
Y
C3 Metals continues to define copper resource at Khaleesi project with latest drill results
2d
Y
Yum China Q1 Earnings Call Highlights
2d
Y
Veralto Q1 Earnings Call Highlights
2d
Y
Trustmark Highlights Record 2025 Net Income at Annual Meeting as Shareholders Approve Proposals
2d
Y
GSK Q1 Earnings Call Highlights
2d
Y
Fannie Mae Q1 Earnings Call Highlights
2d
Y
Symrise Q1 Earnings Call Highlights
2d
Y
More →